131 related articles for article (PubMed ID: 27276208)
1. 18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
do Vale RH; Queiroz MA; Coutinho AM; Buchpiguel CA; de Menezes MR
Clin Nucl Med; 2016 Sep; 41(9):724-5. PubMed ID: 27276208
[TBL] [Abstract][Full Text] [Related]
2. Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Kim SS; Jeon YK; Lee SH; Kim BH; Kim SJ; Kim YK; Kim IJ
Korean J Intern Med; 2014 May; 29(3):383-7. PubMed ID: 24851075
[TBL] [Abstract][Full Text] [Related]
3. FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images.
Li M; Lu H; Gao Y
Clin Nucl Med; 2013 Nov; 38(11):916-8. PubMed ID: 24089062
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
5. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
6. Interlesional 'flip-flop' between
Basu S; Kalshetty A; Fargose P
Natl Med J India; 2017; 30(1):48. PubMed ID: 28731009
[No Abstract] [Full Text] [Related]
7. Unusual case of solitary functioning bone metastasis from a "parathyroid adenoma": imagiologic diagnosis and treatment with percutaneous vertebroplasty--case report and literature review.
Qiu ZL; Wu CG; Zhu RS; Xue YL; Luo QY
J Clin Endocrinol Metab; 2013 Sep; 98(9):3555-61. PubMed ID: 23861459
[TBL] [Abstract][Full Text] [Related]
8. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
10. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
Moragas M; Soler M; Riera E; García JR
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Al-Bulushi NK; Abouzied ME
Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
[TBL] [Abstract][Full Text] [Related]
12. Localization of metastatic parathyroid carcinoma by 18F FDG PET scanning.
Gardner CJ; Wieshmann H; Gosney J; Carr HM; Macfarlane IA; Cuthbertson DJ
J Clin Endocrinol Metab; 2010 Nov; 95(11):4844-5. PubMed ID: 21051579
[No Abstract] [Full Text] [Related]
13. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.
Betea D; Bradwell AR; Harvey TC; Mead GP; Schmidt-Gayk H; Ghaye B; Daly AF; Beckers A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3413-20. PubMed ID: 15240624
[TBL] [Abstract][Full Text] [Related]
14. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
16. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
[TBL] [Abstract][Full Text] [Related]
17. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
18. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
19. Malignant ovarian Brenner tumor. A case report evaluated with (18)F-FDG PET/CT.
Mena LM; Carmona E; Maza FR; Guiote MV; Moreno E; Vallejo JA
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):337-8. PubMed ID: 25890890
[No Abstract] [Full Text] [Related]
20. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
Sahin E; Zincirkeser S; Akcan AB; Elboga U
J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
